The Australian Breast Device Registry (ABDR) is a Commonwealth Government health initiative that records information on surgeries involving breast devices, such as breast implants. Managed by Monash University, the ABDR is endorsed by major surgical societies in Australia.
To identify and report on possible trends and complications associated with breast device surgery; to track the long-term safety and performance of implantable breast devices; and to identify best surgical practice and optimal patient health outcomes.
Your information makes an invaluable contribution to the ABDR. We are a long-term project to help safeguard the health of people undergoing breast device surgery. For many patients the ABDR provides peace of mind that their device details are recorded.
7 February 2023: TGA has updated information about the risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in relation to implants’ surface texture. BIA-ALCL is a rare type of cancer of the immune system. BIA-ALCL is not breast cancer.
Updated TGA web pages:
- FOR CONSUMERS: Breast implant associated cancer (BIA-ALCL): Information for consumers | Therapeutic Goods Administration (TGA)
- FOR HEALTH PROFESSIONALS: BIA-ALCL: Information for health professionals | Therapeutic Goods Administration (TGA)
- UPDATED SAFETY ALERT: Breast implants and anaplastic large cell lymphoma | Therapeutic Goods Administration (TGA)
The TGA has a dedicated breast implant hub for information about breast implants.
20 September 2022: The TGA advised of emerging reports from the US, of squamous cell carcinoma (SCC) and various lymphomas found in the capsule or scar tissue around breast implants. These are not the same as BIA-ALCL and they are not breast cancers. The TGA wrote, ‘The risk of squamous cell carcinoma and other lymphomas occurring in the tissue around breast implants appears to be extremely rare.’ Read in full.
Provides information about BIA-ALCL for the Victorian public.
Contact the ABDR
1800 998 722
Contributing Surgeons & Clinicians